Genevieve Boland · researcher (ORCID 0000-0002-7522-6173) · YYNN

Genevieve Boland

? TBD

researcher (ORCID 0000-0002-7522-6173)

Ratings 0

Nobody has rated this yet. Be the first!

Works 3

Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma

scientific article published on 12 April 2018

A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of BRAF-mutated Melanoma to MAPK Inhibitors

scientific article published on 02 August 2019

Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma

scientific article published on 21 March 2018

Lists 0